EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 11 listopada 2024. Database contains 4821 unique substances/entries.
Filter the list
|
PANTERA; QUIZALOFOP-P-TEFURYL
|
414-200-4
|
119738-06-6
|
Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2 |
||
|
SCH.19927 DIBENZOYLTARTRATE
|
404-390-7
|
88976-55-0
|
Flam. Sol. 1; Skin Sens. 1 |
||
|
(R)-EPICHLOROHYDRIN
|
424-280-2
|
51594-55-9
|
Flam. Liq. 3; Carc. 1B; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.
|
270-088-5
|
68410-71-9
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.
|
270-349-3
|
68425-35-4
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
307-769-4
|
97722-19-5
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
|||
|
SCARLET DER 8107
|
429-070-4
|
214362-06-8
|
Eye Dam. 1 |
||
|
LATEMUL S-180 A
|
410-540-2
|
116726-92-2
|
Skin Irrit. 2; Skin Sens. 1 |
||